Beurs.nl monitor iconMarkt Monitor
  • AEX +0,32 819,56 +0,04%
  • DE40 0,00 20.374,10 0,00%
  • US500^ 0,00 5.358,26 0,00%
  • US30^ 0,00 40.214,00 0,00%
  • EUR/USD 0,00 1,1327 -0,29%
  • WTI 0,00 61,48 0,00%
  • Gold spot -18,35 3.219,12 -0,57%

Univar Terug naar discussie overzicht

PRESS RELEASE:S&P Rates Univar Corp

2 Posts
| Omlaag ↓
  1. forum rang 10 voda 10 september 2007 20:09
    PRESS RELEASE:S&P Rates Univar Corp Credit 'B';Outlook Stable

    The following is a press release from Standard & Poor's:


    NEW YORK (Standard & Poor's) Sept. 10, 2007--Standard & Poor's Ratings Services said today that it assigned its 'B' corporate credit rating to Univar Inc., a wholly owned subsidiary of Univar N.V. The outlook is stable.

    At the same time, Standard & Poor's assigned ratings to the proposed $1.25 billion senior secured term loans of Univar Inc., Univar U.K. Holdings Ltd., and Ulixes Acquisition B.V. The $105 million U.S. term loan A, $170 million U.K. term loan A, and $975 million term loan B are rated 'B' with a '3' recovery rating, indicating the likelihood of meaningful (50%-70%) recovery in the event of a payment default.

    CVC Capital Partners, a private equity sponsor, is buying Univar. Proceeds of the term loans, $510 million of borrowings under an unrated proposed asset-based revolving credit facility (including a $100 million first-in-last-out tranche), $600 million senior subordinated notes, and common equity of $1.191 billion contributed by the equity sponsor will be used to finance the acquisition. The transaction is subject to approval by the company's shareholders and is expected to close during the third quarter of 2007.

    "The ratings on Univar reflect its highly leveraged capital structure," said Standard & Poor's credit analyst Robyn Shapiro. In addition, Univar operates in a fragmented and competitive industry with operating margin pressures. Continued industry consolidation will most likely result in pressure for further acquisition activity. These factors are offset by the company's leading market positions; satisfactory product, customer, supplier, and geographic diversity; and flexible cost structure, with margin stability in downturns.

    Bellevue, Wash.-based Univar is a leading global chemical distributor with annual sales of over $8 billion, pro forma for the April 2007 acquisition of CHEMCENTRAL.

    Complete ratings information is available to subscribers of RatingsDirect, the real-time Web-based source for Standard & Poor's credit ratings, research, and risk analysis, at www.ratingsdirect.com. All ratings affected by this rating action can be found on Standard & Poor's public Web site at www.standardandpoors.com; select your preferred country or region, then Ratings in the left navigation bar, followed by Credit Ratings Search.



  2. forum rang 10 voda 3 januari 2023 09:25
    Chemiedistributeur Brenntag staakt overnamegesprekken met Univar

    Sinds november in gesprek.

    (ABM FN-Dow Jones) Brenntag heeft de overnamegesprekken met Univar Solutions gestaakt. Dit maakte Brenntag maandagavond laat bekend.

    Sinds november was de Duitse grootmacht in gesprek met de kleinere Amerikaanse concurrent over een overname.

    In reactie liet Univar weten dat het nu verder zal praten met andere partijen die interesse toonden.

    De activistische aandeelhouder PrimeStone Capital, goed voor een belang van circa 2 procent in Brenntag, eiste in december dat Brenntag de overnamegesprekken met Univar zou staken. PrimeStone zag Brenntag liever eigen aandelen inkopen en zich opsplitsen in twee aparte bedrijven. Een overname van Univar zou een langdurig goedkeuringsproces door de toezichthouders opleveren, zo vreesde PrimeStone, en ook de winst drukken.

    Een combinatie van Brenntag en Univar zou een grotere distributeur van speciaalchemicaliën opleveren dan IMCD en Azelis, zo zei analist Henk Veerman van zakenbank Kempen eind november tegen ABM Financial News.

    Maar aangezien de integratie na een overname veel tijd en energie kost, dacht Veerman dat dit kansen zou bieden aan Azelis en IMCD om in bepaalde regio's marktaandeel te winnen. Ook zou Brenntag, omdat het de handen vol zou hebben aan de overname van Univar, vermoedelijk minder of zelfs helemaal geen aanvullende acquisities willen doen. Dit maakte dat IMCD en Azelis bij het doen van overnames een concurrent minder zouden hebben.

    Door: ABM Financial News.

    info@abmfn.nl

    Redactie: +31(0)20 26 28 999
2 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.163
AB InBev 2 5.544
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.507
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.931
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.892
Aedifica 3 927
Aegon 3.258 323.213
AFC Ajax 538 7.093
Affimed NV 2 6.306
ageas 5.844 109.909
Agfa-Gevaert 14 2.074
Ahold 3.538 74.363
Air France - KLM 1.025 35.331
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.072
Alfen 16 25.503
Allfunds Group 4 1.525
Almunda Professionals (vh Novisource) 651 4.252
Alpha Pro Tech 1 17
Alphabet Inc. 1 427
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.271
AMG 972 134.761
AMS 3 73
Amsterdam Commodities 305 6.757
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.106
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.097
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.380
Aroundtown SA 1 221
Arrowhead Research 5 9.759
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.700
ASML 1.767 112.340
ASR Nederland 21 4.522
ATAI Life Sciences 1 7
Atenor Group 1 523
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.351
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.463